New imaging agent could spot hidden cancer spread in the abdomen

NCT ID NCT07219238

Recruiting now Diagnosis Sponsor: GE Healthcare Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times

Summary

This study tests a new PET/CT scan using an investigational agent (GEH300079) to detect peritoneal carcinomatosis—cancer spread in the lining of the abdomen—in people with colorectal, gastric, ovarian, or pancreatic cancers. About 175 adults with known or suspected spread will receive the scan before planned surgery. The goal is to see if this scan is more accurate than standard imaging for finding cancer spread, which could help guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

BAMF Health
NOT_YET_RECRUITING

Grand Rapids, Michigan, 49503, United States
Karolinska Universitetssjukhuset
RECRUITING

Stockholm, 17176, Sweden

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER GASTRIC CANCERS GASTRIC CANCERS OVARIAN CANCERS OVARIAN CANCERS PANCREATIC DUCTAL ADENOCARCINOMA PANCREATIC DUCTAL ADENOCARCINOMA